CD8A and COVID-19: detected reactive CD8+ T cells toward a wide scope of SARS-CoV-2 proteins in 88.5% of COVID-19 individuals, mainly targeting ORF1ab region which may relate to the longer protein fragment length and containing more prominent epitopes (16).